RETRACTED: Correlations between peroxisome proliferator activator receptor γ, Cystatin C, or advanced oxidation protein product, and atherosclerosis in diabetes patients-Reference-Cited by-同舟云学术

RETRACTED: Correlations between peroxisome proliferator activator receptor γ, Cystatin C, or advanced oxidation protein product, and atherosclerosis in diabetes patients

Published:2015-03 Issue:3 Volume:211 Page:235-239
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Yang Haiyan,Wang Chun,Guo Meizi,Zhou Yihua,Feng Zhenhua,Yin Zhenyu

Funder

Nanjing Medical Science and Technology Development Project Funding

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference41 articles.

1. Five stages of evolving beta-cell dysfunction during progression to diabetes;Weir;Diabetes,2004

2. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N. Engl. J. Med.,1998

3. Diabetes and stroke: part one—risk factors and pathophysiology;Baliga;Curr. Cardiol. Rep.,2006

4. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management;Beckman;JAMA,2002

5. Diabetic kidney disease;A.a.O.D. Educators;Diabetes Educ.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PPARs for therapy of atherosclerosis: A review;International Journal of Biological Macromolecules;2023-07

2. Value of cystatin C in predicting recurrence in patients with severe diabetic foot and diabetic foot ulcer;Biomarkers in Medicine;2023-03

3. Correlation between serum cystatin C level and renal microvascular perfusion assessed by contrast-enhanced ultrasound in patients with diabetic kidney disease;Renal Failure;2022-10-17

4. Correlation between Serum Cystatin C Level and Retinal Blood Flow in Patients with Essential Hypertension;Ophthalmic Research;2022

5. Retraction notice to “Correlations between peroxisome proliferator activator receptor gamma, Cystatin C, or advanced oxidation protein product, and atherosclerosis in diabetes patients” [Pathology - Research and Practice 211/3 (2014) 235-239];Pathology - Research and Practice;2018-10